000			01850 a2200529 4500
005			20250518101626.0
264		0	_c20210628
008			202106s 0 0 eng d
022			_a2050-6414
024	7		_a10.1177/2050640620924274 _2doi
040			_aNLM _beng _cNLM
100	1		_aKirstein, Martha M
245	0	0	_aSecondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis. _h[electronic resource]
260			_bUnited European gastroenterology journal _c07 2020
300			_a716-724 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aBile Duct Neoplasms _xepidemiology
650	0	4	_aC-Reactive Protein _xanalysis
650	0	4	_aCholangitis, Sclerosing _xblood
650	0	4	_aCritical Illness _xmortality
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aIntensive Care Units _xstatistics & numerical data
650	0	4	_aLiver Failure, Acute _xblood
650	0	4	_aLiver Function Tests
650	0	4	_aLiver Transplantation _xmethods
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Assessment _xstatistics & numerical data
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aBook, Thorsten
700	1		_aManns, Michael P
700	1		_avon Hahn, Thomas
700	1		_aVoigtländer, Torsten
773	0		_tUnited European gastroenterology journal _gvol. 8 _gno. 6 _gp. 716-724
856	4	0	_uhttps://doi.org/10.1177/2050640620924274 _zAvailable from publisher's website
999			_c30931720 _d30931720